| Description: | Correlogic Systems, Inc. is a clinical proteomics company engaged in the development of tools and processes for proteomic and genomic-based clinical diagnostic systems and new drug discovery. Correlogic has developed a patent-pending, scientifically validated methodology for the early detection of various cancers and other diseases through the use of high throughput bioassays and pattern discovery software. Our technologies have a wide range of applications for the creation of disease diagnostic models, biomarker discovery, and new drug discovery processes. Correlogic is also a clinical laboratory regulated under the Clinical Laboratory Improvement Amendments of 1988, designated to perform high complexity testing. Correlogic has entered into agreements to provide an ovarian cancer testing service in cooperation with the nation's two premier diagnostic laboratories, Laboratory Corporation of America and Quest Diagnostics. |
|---|
